The objective of this work was to conduct an in vivo comparison of nanoparticles and microparticles as vaccine delivery systems. Poly (lactide-co-glycolide) (PLG) polymers were used to create nanoparticles size 110 nm and microparticles of size 800-900 nm. Protein antigens were then adsorbed to these particles. The efficacy of these delivery systems was tested with two protein antigens. A recombinant antigen from Neisseria meningitides type B (MenB) was administered intramuscularly (i.m.) or intraperitonealy (i.p.). An antigen from HIV-1, env glycoprotein gp140 was administered intranasally (i.n.) followed by an i.m. boost. From three studies, there were no differences between the nanoparticles and microparticles formulations. Both particles led to comparable immune responses in mice. The immune responses for MenB (serum bactericidal activity and antibody titers) were equivalent to the control of aluminum hydroxide. For the gp140, the LTK63 was necessary for high titers. Both nanoparticles and microparticles are promising delivery systems. ©2008 Landes Bioscience.
CITATION STYLE
Wendorf, J., Chesko, J., Kazzaz, J., Ugozzoli, M., Vajdy, M., O’Hagan, D., & Singh, M. (2008). A comparison of anionic nanoparticles and microparticles as vaccine delivery systems. Human Vaccines, 4(1), 44–49. https://doi.org/10.4161/hv.4.1.4886
Mendeley helps you to discover research relevant for your work.